Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brilinta
Biotech
PhaseBio taps a manufacturing partner for Brilinta-reversing med
PhaseBio is signing a manufacturing partner for its Brilinta reversal agent as it ushers the drug through phase 3 and, it hopes, FDA approval.
Amirah Al Idrus
Mar 11, 2021 9:50am
PhaseBio eyes phase 2 for Brilinta-reversing drug
Mar 19, 2019 9:33am
PhaseBio nets $34M to advance Brilinta reversal agent, PAH drug
Sep 5, 2018 8:00am
AZ sues exec Luke Miels after his defection to GSK
May 16, 2017 9:52am
